Review of CNN special “The Last Heart Attack”
I have a guest post up on Gary Schwitzer’s blog critiquing Sanjay Gupta’s promotion of calcium scans and overhyping of extreme diets.
View ArticleSunday links
David Rind recently revived his blog Evidence in Medicine and has a post up on the SHARP trial. The SHARP trial, which I discussed recently on this blog and on Gooznews, is the basis for Merck’s...
View ArticleHayward and Krumholz: Open Letter to the Adult Treatment Panel IV of the...
Rodney Hayward and Harlan Krumholz have published an open letter to the committee that is currently engaged in writing updated guidelines for cardiovascular risk reduction. Their letter challenges the...
View Article“Be Brave”
In January, I blogged about an open letter by Harlan Krumholz and Rodney Hayward to the panel that is currently engaged in writing new guidelines for cholesterol management. As discussed in my post,...
View ArticleAlzheimer’s disease, familial hypercholesterolemia, and clinical trials
Welcome Jesse Ballenger to the blogosphere. Jesse is a historian who specializes in the history of medicine and is the author of Self, Senility and Alzheimer’s Disease in Modern America. Gary...
View ArticleDo PCSK9 inhibitors affect diabetes risk?
Two PCSK9 inhibitors, evolocumab and alirocumab, are under consideration at the FDA and will be the subject of advisory committee meetings on June 9 and 10. Evolocumab and alirocumab are monoclonal...
View ArticleDiminishing returns in medical therapy
I’m a few months late, but I want to mention an editorial by Rodney Hayward that was published in The BMJ in December 2015. His topic is treatment of diabetes, but the principles he discusses also...
View ArticleLDL-Lowering Genetic Variants Linked to Increased Risk of Diabetes
–What can genetic studies tell us about the risk of developing diabetes with cholesterol-lowering therapies? This post was first published on MedPageToday and CardioBrief.org. In a study published in...
View Article
More Pages to Explore .....